[go: up one dir, main page]

AU2007905961A0 - Device for inhibition of sleep disorders - Google Patents

Device for inhibition of sleep disorders

Info

Publication number
AU2007905961A0
AU2007905961A0 AU2007905961A AU2007905961A AU2007905961A0 AU 2007905961 A0 AU2007905961 A0 AU 2007905961A0 AU 2007905961 A AU2007905961 A AU 2007905961A AU 2007905961 A AU2007905961 A AU 2007905961A AU 2007905961 A0 AU2007905961 A0 AU 2007905961A0
Authority
AU
Australia
Prior art keywords
inhibition
sleep disorders
sleep
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007905961A
Inventor
Frederick John Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2007905961A0 publication Critical patent/AU2007905961A0/en
Abandoned legal-status Critical Current

Links

AU2007905961A 2007-10-31 Device for inhibition of sleep disorders Abandoned AU2007905961A0 (en)

Publications (1)

Publication Number Publication Date
AU2007905961A0 true AU2007905961A0 (en) 2007-11-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP2010187A4 (en) Compounds for diseases and disorders
ZA200806074B (en) Compounds for the treatment of inflammatory disorders
IL192690A0 (en) Hydantoin derivatives for the treatment of inflammatory disorders
AU2008281877A8 (en) The use of benzamide derivatives for the treatment of CNS disorders
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
AU2008272903A8 (en) Treatment for anxiety
EP1983972A4 (en) Compounds for the treatment of metabolic disorders
IL195203A0 (en) Compounds for the treatment of metabolic disorders
IL192852A0 (en) Compounds for the treatment of metabolic disorders
IL195971A0 (en) Use of defibrotide for the inhibition of heparanase
IL195392A0 (en) Compounds for the treatment of metabolic disorders
IL192851A0 (en) Compounds for the treatment of metabolic disorders
IL209417A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
EP2099444A4 (en) Use of d-serine derivatives for the treatment of anxiety disorders
IL198432A0 (en) 2-alkyl-indazole compounds for the treatment of certain cns-related disorders
AU2007905961A0 (en) Device for inhibition of sleep disorders
ZA201004090B (en) Methods for the inhibition of scarring
IL192982A0 (en) Compounds for the treatment of metabolic disorders
HK1123300A (en) Compounds for the treatment of inflammatory disorders
HK1148208A (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
HK1146899A (en) Methods for the inhibition of scarring
HK1144778A (en) Compounds for the treatment of metabolic disorders
HK1174786A (en) Compounds for the treatment of neurologic disorders
HK1124486A (en) Compounds for the treatment of metabolic disorders
HK1122187A (en) Compounds for the treatment of metabolic disorders